Latest market price
92.24
-5.32-5.45%
OverviewShort InterestFilings
KNSAQT77Kiniksa Pharmaceuticals International, plc·NASDAQ
92.24-5.45%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 20268-KCurrent report
Oct 27, 202610-QQuarterly report
Oct 22, 20268-KCurrent report
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 21, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Jul 31, 20264Statement of changes in beneficial ownership
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 28, 20268-KCurrent report
Jul 28, 202610-QQuarterly report
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 436
Page
▼
/ 18